Double Silver for Naib Subedar Gulveer Singh.
Naib Subedar Gulveer Singh clinches his second silver medal at the 2026 Asian Games, finishing second in the men’s 1500m with a time of 3:36.72. 🇮🇳
Following his silver in the 10,000m, Gulveer once again exemplifies the grit, endurance and excellence of an Indian Army athlete.
Two Silvers already, with the Men’s 5000m Final still to come.
Best wishes for the final challenge. Go for Gold, Gulveer.
#MissionOlympicsWing
#ArmySportsControlBoard
#AsianGames2026
#Cheer4Bharat
#Athletics
@adgpi@SpokespersonMoD@HQ_IDS_India@IndiaSports@NorthernComd_IA@easterncomd@westerncomd_IA@SWComd_IA@IaSouthern@suryacommand
Congratulations Vithya!!
Records are meant to be broken & there is no greater reward for an athlete than to see the next generation go beyond the boundaries we once set. Vithya Ramraj breaking my 43-year-old national record in the 400m hurdles is an incredibly special moment.
Congratulations to Murali Sreeshankar on winning the Silver Medal 🥈 in the Men’s Long Jump Final at the #AsianGames2026!
Your power, precision and perseverance have once again put the Tricolour on the podium. A proud moment for India! 🇮🇳👏
#Cheer4Bharat#TeamIndia #BaarBaarBharatHarBaarBharat
India’s Yashvir Singh and Rohit Yadav secured silver and bronze medals respectively in the men’s javelin throw at the Asian Games in Aichi-Nagoya.
Yashvir produced a personal best of 85.72m in his final attempt, while Rohit recorded 84.35m, giving India a double podium finish.
Follow the complete story on #PBSHABD. Register now at https://t.co/0uMyeVb8Eq
#AsianGames2026 #YashvirSingh #RohitYadav #JavelinThrow #TeamIndia #Athletics #PBSHABD
The IIT story people know is software, campuses, and startups. The quieter one is this: relapsed blood-cancer patients in India no longer have to fly west for CAR-T / pay ~₹4 crore. IIT Bombay designed NexCAR19. Tata Memorial trialled it. CDSCO approved it.
Standard oncology relies heavily on imported drugs and protocols, a team at IIT Bombay (led by Prof. Rahul Purwar, alongside researchers Alka Dwivedi and Atharva Karulkar) spent over a decade developing India’s 1st indigenous CAR-T cell therapy: NexCAR19 (actalycabtagene autoleucel).
In partnership with Tata Memorial Centre (led clinically by Dr. Hasmukh Jain and Dr. Gaurav Narula) and spun off as ImmunoACT, the therapy moved from academic labs to clinical trials, ultimately securing CDSCO regulatory approval in Oct 2023.
What the Science Actually Does....
For patients with relapsed / refractory B-cell blood cancers (such as B-cell lymphomas and B-ALL, age 15+), doctors extract the patient's own T-cells via leukapheresis. The lab uses a viral vector to genetically engineer these cells to express a Chimeric Antigen Receptor (CAR) targeting the CD19 protein on cancerous B-cells, expand them, and infuse them back into the patient as a targeted living treatment.
Commercial US CD19 CAR-Ts (like Kymriah or Yescarta) used murine (mouse-derived) scFv binding domains, which carry immunogenicity concerns. The IIT Bombay team engineered a humanized CD19-directed construct.
In clinical studies, ImmunoACT reported a favorable tolerability profile with lower rates of severe high-grade Cytokine Release Syndrome (CRS) and little / no high-grade ICANS in the registrational studies, though mild-to-moderate CRS remains a common expected immune response.
Western list prices for CD19 CAR-T therapies run upwards of $400,000 (~₹3.8+ Crore) per patient. NexCAR19's product price was launched in the ₹30-40 Lakh range, ~1/10th the US list price.
NexCAR19 is not a universal cure, nor does it replace frontline chemotherapy / bone marrow transplants for all cancers. It is approved specifically for difficult, relapsed CD19-positive B-cell malignancies where prior standard lines of therapy have failed.
However, as India's 1st homegrown approved CAR-T therapy, it is a landmark translational achievement: taking advanced synthetic biology out of an academic lab, passing multi-center clinical trials at Tata Memorial, and offering Indian patients access to advanced cell-and-gene therapy at home at ~10% of Western list prices.
Bharat is rising. 🙏🙏
🇮🇳 Silver Soars High for India.
Heartiest congratulations to Naib Subedar Sarvesh Kushare on winning the Silver Medal in the men’s High Jump at the Asian Games Aichi–Nagoya 2026.
Clearing an impressive 2.25m.
A proud moment for Indian athletics and #ArmySports. May he continue to scale greater heights and bring many more laurels to Bharat.🇮🇳
#MissionOlympicsWing #ArmySportsControlBoard
#AsianGames2026
#Cheer4Bharat
#Athletics
@adgpi@SpokespersonMoD@HQ_IDS_India@IndiaSports@NorthernComd_IA@easterncomd@westerncomd_IA@SWComd_IA@IaSouthern@suryacommand
Congratulations to Parul Chaudhary on winning bronze medal in women's 3000 metres Steeplechase event at #AsianGames with personal best time of 9:08.67.
#Cheer4Bharat 🇮🇳